Active Ingredient History

  • Now
Lisofylline (LSF) is a synthetic small molecule with novel anti-inflammatory properties. LSF can effectively prevent type 1 diabetes in preclinical models and improves the function and viability of isolated or transplanted pancreatic islets. It is a metabolite of pentoxifylline.   Wikipedia

  • SMILES: C[C@@H](O)CCCCN1C(=O)N(C)c2ncn(C)c2C1=O
  • Mol. Mass: 280.33
  • ALogP: -0.02
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
1-(5'-hydroxyhexyl)-3,7-dimethylxanthine | 1-(5r-hydroxyhexyl)-3,7-dimethylxanthine | 1h-purine-2,6-dione, 3,7-dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl- | 3,7-dimethyl-1-(5-hydroxyhexyl)xanthine | a-802710 | bl 194 | ct-1501r | lisofylline | lysofylline | protec


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue